Loic Maurel will begin serving as chief operating officer of ExonHit Therapeutics as of July 1. The company said that he will be appointed CEO at the next meeting of the French firm’s supervisory board.
Maurel previously served as president and CEO of Debiovision, a Canadian pharmaceutical development company. Before that, he was vice president of marketing and specialty business for Novartis Canada.
Maurel received his MD from the University of Bordeaux in France.
Cristopher McReynolds was recently named president and chief executive officer of Satoris. He replaced Patrick Lynn, who was named executive chairman. McReynolds previously was vice president of business development in the Molecular Diagnostics unit of Affymetrix.
Gene Cartwright, formerly president of GE Healthcare’s molecular diagnostics business, has been named CEO of Omnyx, a newly formed joint venture between GE Healthcare and the University of Pittsburgh Medical Center. The new JV will develop and sell advanced digital imaging systems for pathologists.
Cartwright joined GE Healthcare in late 2005 from Abbott Laboratories, where he served as vice-president of strategic programs for its molecular diagnostics business.